The international healthcare firm Rayont Inc (OTCMKTS:RAYT), which is involved with alternative medicinal products as well as services, has been in focus among investors for the better part of this year.
The stock has managed to clock gains of as much as 90% so far in 2021 and in light of such gains; it might be a good time for investors to take a closer look at Rayont. Although there has been no news about the company in recent times, it might be a good idea to take a look at Rayont’s financial results for the six month period that ended on March 31, 2021. Those results had been announced by the company back in May.
The performance from Rayont was quite strong. The company managed to generate revenues of as much as $1,409,542 in the six month period and that proved to be much higher than the $844,682 that it had generated in the corresponding period in the previous year.
On the other hand, the net income also jumped to $792,054 from $357,064 in the prior year period. At the end of the period, the company had a cash balance of $79,412 which was actually lower than the cash balance of $196,174 at the end of the corresponding period last year.
